Register for our free email digests:
Teleflex Medical
http://www.teleflexmedical.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Teleflex Medical
JPM 2021: EY Says Pandemic Leaves Medtech With $500Bn In M&A Firepower
EY’s M&A Firepower report predicts very active M&A activity for medtechs in 2021, driven by diagnostics and digital health, but with some headwinds remaining.
Teleflex Subsidiary Faces Federal False Claims Investigation
Urology device developer NeoTract, which Teleflex purchased in 2017, is now under scrutiny for potential FCA violations.
Teleflex Bets Percutaneous Laparoscopy Will Be MIS Game Changer
Story and Podcast: Teleflex Medical launched in March a novel portfolio of miniaturized percutaneous surgical instruments that have the same functionality as full-sized laparoscopic instruments, but allow surgeons to access the abdominal cavity using trocar-less entry and much smaller incisions than those required in traditional laparoscopy. Teleflex execs say the technology is a game changer, and the company hopes percutaneous laparoscopy will become the standard of care for the 4 million laparoscopic procedures performed annually in the US.
Warning Letter Close-Outs – September 2015
Twelve FDA close-out letters were released in September.
Company Information
- Industry
-
Medical Devices
- Surgical Equipment & Devices